期刊名称：JOURNAL OF GENERAL VIROLOGY
|
ISSN： | 0022-1317
|
|
版本： | SCI-CDE
|
|
出版频率： | Monthly
|
|
出版社： | SOC GENERAL MICROBIOLOGY, MARLBOROUGH HOUSE,BASINGSTOKE RD,SPENCERS WOODSREADING, ENGLAND, RG7 1AG
|
|
期刊网址： | http://vir.sgmjournals.org/
| |
影响因子： | 3.092(2008) |
| 主题范畴： | VIROLOGY; BIOTECHNOLOGY & APPLIED MICROBIOLOGY |
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
JGV, a dynamic journal at the forefront of virology today, attracts an international audience and publishes over 3000 pages of rigorously peer-reviewed, high-calibre research from around the world.
The diverse scope of the journal, which reflects the evolving nature of virology today, includes topics on all aspects of animal, plant, insect, bacterial and fungal viruses; transmissible spongiform encephalopathies; molecular biology and immunology; virus杊ost interactions and antiviral compounds. |
Instructions to Authors
Submission of papers for publication
ESPERE online submission system:
Authors must submit their papers via our online submission and peer review system, ESPERE. Papers should be prepared as described in these Instructions. .
Enquiries concerning online submission and peer review should be directed to jgv.ospr@sgm.ac.uk
Ensure that:
The paper complies with the restrictions on paper length. The total number of words in the main text of the paper, and in the Summary, together with the number of figures and tables are stated on the title page.
A Statement of Authorship is provided.
Permission has been obtained for any citations of personal communications or unpublished results; this should be confirmed in a covering message.
Citation of references in the text and References list conforms with JGV style.
Use and definition of abbreviations conforms with JGV style.
Papers that are cited, but not yet published, are supplied as additional files.
Any supplementary material associated with the paper is supplied as an additional file, for peer-review with the paper. |
Papers that exceed the length limits will not be considered; papers lacking a Statement of Authorship or the necessary information on paper length will not be reviewed until these are provided.
Any general queries should be directed to the Editorial Office staff:
Tel +44 118 988 1833; Fax +44 118 988 1834; E-mail jgv@sgm.ac.uk
Scope of the Journal
Journal of General Virology aims to publish papers that describe original research in virology and contribute significantly to their field. It is concerned particularly with fundamental studies. Papers must be in English. Standard papers, short communications and review articles are published.
Papers that describe new materials or methods without applying them to research are generally not acceptable. Preliminary or inconclusive data will not be published. Data that differ only in a minor way from previously published results are not acceptable; this applies for instance to comparisons of nucleotide sequences with closely similar published sequences. Papers dealing with clinical or epidemiological aspects of virology are welcome provided that they contain new information on basic biological processes or virus杊ost interaction.
Prior publication
Submission of a paper will be taken to imply that it reports unpublished work that is not under consideration for publication elsewhere. Papers whose whole or partial contents (excluding sequence data) have previously been made available on a publicly accessible website will not be considered for publication.
Authorship
All papers submitted must be accompanied by a statement that (i) all the authors have agreed to its submission and are responsible for its contents and (ii) all the authors have agreed that the corresponding author may act on their behalf regarding any subsequent processing of the paper. This statement should preferably be signed by all the authors; the corresponding author may sign on behalf of the other authors provided that he or she has written consent from them agreeing to points (i) and (ii) above. Papers lacking a statement of authorship will not be reviewed until one is provided.
| The statement of authorship should be included with the ESPERE online submission as an additional file (e.g. PDF or scanned image file) or incorporated into the covering message; alternatively it may be faxed to the Editorial Office (+44 118 988 1834). If providing a statement of authorship in this form might cause unreasonable delay, a brief statement in the covering message indicating that the corresponding author has signed permission from the other authors to act on their behalf will suffice. |
Copyright
If a paper is accepted for publication in Journal of General Virology, the authors (or other copyright holder) will be asked to download a copyright assignment form and transfer to the Society for General Microbiology the copyright (including electronic reproduction rights) of the paper. Neither a whole paper nor a substantial part of a paper may subsequently be published elsewhere in the same form, in any language or any medium, without the consent of the Society, except that authors may mount a PDF file of the published version of their paper on their own or their institution's website. The PDF file must correspond exactly to the paper as printed in the Journal. PDFs can be downloaded from the JGV Online website or may be obtained from the Editorial Office on request (a handling charge may be made). Papers must not be mounted before publication in the print copy of Journal of General Virology; nor must they be mounted on a server for the purpose of commercial sale or systematic external distribution by a third party (e.g. via an e-print server). Click here to download a Copyright Transfer Agreement form.
Form of papers submitted
Restrictions on paper length
Journal of General Virology publishes standard papers, short communications and reviews. These are restricted in length as described below, in order to improve the quality and clarity of the Journal. Any manuscripts submitted that exceed these limits will be returned immediately to the authors. The total number of words in the main text of the paper, and in the Summary, together with the number of figures and tables must be stated on the title page. Papers lacking this information will not be reviewed until it is provided.
The Editors wish to emphasize that the review process and scientific criteria for acceptance of standard papers and short communications are identical.
Standard ('full-length') papers. The maximum permitted length of these is as follows: text (Introduction, Methods, Results and Discussion, but excluding figure legends and tables), 5000 words; number of tables and figures combined, eight; summary, 250 words. There are no restrictions on the number of references.
Standard papers are divided into the following sections: Summary, Introduction, Methods, Results, Discussion, Acknowledgements and References. Repetition of content between sections must be avoided. A combined Results and Discussion section is permitted.
Short communications. The maximum permitted length of these is as follows: text (excluding figure legends and tables), 2000 words; number of tables and figures combined, three; summary, 150 words. There are no restrictions on the number of references.
Short communications must report completed work, not preliminary findings: they are an alternative format for describing smaller pieces of work. They contain Summary and Reference sections but the main text is not divided into sections. Methods should be described briefly within the text, not within figure legends.
Review articles. A small number of these are published each year. They aim to give an overview of a particular subject suitable for a wide audience. Most reviews are invited. Unsolicited reviews will be considered but intending authors should consult the Editor-in-Chief in advance.
General style and layout
In addition to reading the following, intending authors are advised to examine a current copy of the Journal for the layout and conventions used.
The past tense should be used throughout in describing new results, and the present tense in referring to previously established and generally accepted results. The Concise Oxford Dictionary (Oxford University Press) should be used as the standard for spelling and the CBE manual Scientific Style and Format (6th edn, Cambridge University Press) as an editorial guide. Authors are encouraged to use their own style of writing provided that it is concise and conforms to normal English usage.
Title page. The title page should provide the following information: title of paper, names of authors, name and address of the institution(s) of where the work was performed, including the full postal address (plus telephone and fax numbers and e-mail address, if applicable) of the author to whom correspondence should be sent; a shortened running title of not more than 50 letters and spaces; footnotes to indicate present addresses of any authors no longer at the institution where the work was performed; and the number of words in the Summary, and in the main text of the paper, together with the number of figures and tables. The name of the corresponding author will appear on the title page of the published paper; the corresponding author's e-mail address will also be given unless a specific request is made for these to be withheld.
Summary. The Summary is likely to be read by more people than the full paper, and many abstracting services use authors' summaries without modification. It is therefore important that this section is clear and comprehensible in its own right. The Summary should be in the form of a single paragraph. References should not be cited and any abbreviations used must be defined.
Introduction. The Introduction should give a concise background to the present study. It should not present an extended review (up-to-date review articles should be cited wherever possible), nor should it anticipate the Results or Discussion in any detail.
Methods. This section should give sufficient information to allow others to repeat the work. It may contain subsections. Established methods should be very briefly described (for instance, with a reference) and novel methods given in greater detail. The suppliers of chemicals, biological materials and equipment should be indicated if this may affect the results. For bioreagents (e.g. virus strains, antibodies, cell lines) the source (culture collection, company or colleagues) must be adequately documented. Suppliers' addresses should not be given unless this is considered essential for a particular reason.
Results. This section should describe concisely the rationale of the investigation and its outcomes. Overall interpretation of the data belongs in the Discussion. The Results section may be divided into subsections with concise descriptive titles.
Discussion. This section should relate results to previous work and interpret them. It can outline hypotheses based on the work reported. It must not repeat parts of the Introduction or recapitulate the Results section. The Discussion section may also be divided into subsections with concise descriptive titles. The Results and Discussion sections may be combined, and subsections used.
Acknowledgements. This optional short section should follow the Discussion.
References. References in the text should be cited thus: two authors, Banks & Davies (2002) or (Banks & Davies, 2002); three or more authors, Banks et al. (2002) or (Banks et al., 2002). References to papers by the same author(s) in the same year should be distinguished in the text and in the References list by the letters a, b, etc. (e.g. 2002a, or 2002a, b).
|
In the References section papers should be listed alphabetically by first author; papers with three or more authors should be listed in chronological order after any other papers by the first author. For papers with 10 or more authors, the names of the first three only should be given; the remainder should be represented by '& n other authors' (e.g. Banks, A., Davies, C., Franks, E. & 12 other authors). References must include the title of the paper as well as both initial and final page numbers. Titles of journals should be abbreviated according to the system used by MEDLINE. No stops should be used after abbreviated words. References to books should include year of publication, title, edition, editor(s) (if any), place of publication and publisher, in that order. When the reference is to a particular part of a book, the inclusive page numbers and, if appropriate, the title of the article or chapter, must be given. |
Example of a journal reference:
Hannoun, C., Norder, H. & Lindh, M. (2000). An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam. J Gen Virol 81, 2267?272.
Example of a book chapter reference:
Kann, M. & Gerlich, W. H. (1998). Hepatitis B. In Topley and Wilson's Microbiology and Microbial Infections, 9th edn, pp. 745?74. Edited by L. Collier, A. Balows & M. Sussman. London: Arnold.
| Authors who use EndNote or Reference Manager can download the style for SGM journals (select Journal of General Virology or Microbiology; the style is the same for both).
Only papers accepted for publication but not yet published can be cited as 'in press' in the References list, and they must be accompanied by the name of the journal. Any such papers must be included as additional files with the online submission. References to papers not yet accepted should be cited in the text as unpublished results, giving the initials and surnames of all authors. Such papers do not appear in the list of references. References to 'manuscript submitted' or 'manuscript in preparation' are not permitted.
Permission must be secured for all personal communications that are cited in the text. |
Tables. These should be employed selectively and should be generally comprehensible without reference to the text. Each Table should have a concise title; additional material should be given in a legend or footnotes as appropriate, but these should be brief and should not contain experimental detail that could be included in the text. The footnote symbols are *, ? ? ? || and ? to be used in that order.
Figures. This section gives general guidance on preparing figures for publication.The online submission guidelines give specific advice on preparing figures for inclusion in a PDF for submission, where file sizes need to be kept below 1MB. Figures must be designed for both clarity and economy of space. Legends must not repeat the Methods section. Parts of a single figure should be designated (a), (b), etc., and labelled as such on the figure. Figures should be designed to fit into either one or two columns on the journal page. Maximum printed sizes (width x height), including lettering, are 84 x 235 mm or 176 x 235 mm.
Line drawings. These should be of a quality suitable for direct reproduction and approximately twice the size that they will appear. Line drawings should be submitted as (i) original drawings in black ink on white paper; (ii) glossy photographs; or (iii) high-quality computer-generated figures. Symbol sizes and line thicknesses must be chosen for clear visibility after reduction. Symbols should be defined in the legend rather than on the axes. Where possible, the same point symbols should be used for comparable variables in different figures. The preferred symbols are  ,  ,  ,  ,  ,  ,  and  . The scale marks on graphs should be inside the axes. With computer-generated figures special care should be taken over the use of shading and hatching. Tints (shading made up of fine dots) can make file sizes very large, and they often do not reproduce well when printed in the journal. The use of tints should therefore be avoided if possible. If tints are used they should have a screen value of 100 lines per inch or lower. |
Sequence data and schematic diagrams. Diagrams of nucleotide and amino acid sequences, and schematic diagrams of, for example, genome structure and organization, should be prepared 'camera-ready' with a good quality printer. The layout should be designed to fit the journal page economically, i.e. to fill either the full width of the page (176 mm) or a single column (84 mm). The height of the characters should be about 1.5? mm (or 6? point). For printing sequence data at full page width with this size of type, a layout with 80?00 nucleotides per line is appropriate (or 60?0 if there are spaces between the codons). For a single-column layout, 50?0 nucleotides is about right. The lines of sequence should be as close as is consistent with clarity. Use of the single letter amino acid code is preferred. See below for guidelines on reporting sequence data.
Photographs. These should be well-contrasted and approximately final size (maximum width 176 mm). For photomicrographs, magnification should be shown by a bar marker.
|
Digitally generated images. It is usually possible to obtain better reproduction from graphics files than from hard-copy printouts made from these files. The resolution should be at least 300 d.p.i. The preferred file format is TIFF or EPS, but a considerable range of file types generated by various graphics programs can, in principle, be handled; authors should seek detailed guidance from the Editorial Office. In certain cases it may, however, be necessary for appropriate hard-copy to be supplied.
Where images of gels, autoradiograms, etc., have been digitally generated or processed, either directly or after being scanned-in, the hardware and software used must be stated. |
Colour photographs. Colour figures are reproduced free of charge if use of colour is considered by the Editors to be necessary for scientific reasons. Graphics files for colour images should, if possible, be supplied as CMYK, not RGB files.
Supplementary data
Online data that usefully supplement the contents of a paper may be referred to either by including in the paper the URL of the relevant website or by attaching supplementary data files (e.g. tables, figures, sequences, video, etc.) to the paper in JGV Online. In the latter case the material should be supplied as an additional file for peer-reviewed along with the paper: authors should contact the Editorial Office for details.
|
Refereeing and scientific editing
During the online submission process authors should select the Editor who is to handle their paper. To do this the Subject Category field must be completed. The Editor will acknowledge 'receipt' of the paper and send you a reference number. If you are unsure which Editor would be most appropriate, the field should be left to read 'Choose an Editor from this list', If you do not select an Editor the Editorial Office will select an appropriate Editor for you. You will then be sent an acknowledgement stating hte Editor's name and contact details, together with the paper's reference number. Any subsequent queries should be directed to the Editor.
After preliminary examination to establish that a paper appears to be a competent submission within the scope of the Journal, the Editor will assign it to two or more independent referees for review online. These referees will review the paper for originality and significance of the work described and judge its acceptability for publication. There are three possible recommendations: accept, conditional accept and reject. Conditional accept implies that the manuscript requires modifications that could be carried out within a month. The referees may also make critical comments and where necessary suggest improvements or additional experiments which could be done in support of the findings. However, it is the Editor who makes the final decision as to the acceptability of the paper.
Papers are reviewed as quickly as possible, but authors should not usually expect to receive a decision in under 6 weeks.
Copy-editing
Once accepted, a paper is sent copy-edited by the Editorial Office to be copy-edited in preparation for printing. This is done by making use of a wordprocessor file supplied by the author. Papers are copy-edited to the extent necessary to achieve clarity of expression and to conform with the Journal's conventions and standard scientific nomenclature. No changes of substance are made without the authors' consent.
Electronic files for accepted papers
Authors of accepted papers will be asked to supply a wordprocessor file of the final version of their paper, plus electronic files (and/or hard copies) of figures. Details of what is needed will be sent when acceptance is confirmed by the Editor or Editorial Office (see also online submission guidelines for extensive additional information). Advice on file-types for figures is given above.. |
Proofs
Proofs are e-mailed as a PDF. The PDF should be printed and corrections marked on the paper copy. No attempt should be made to edit the PDF electronically. The corrected proof should be sent to the Editorial Office within 3 days (by airmail from outside Europe). If necessary, corrected pages may be sent by fax (+44 118 988 1834) to the Editorial Office or minor corrections may be communicated by telephone (+44 118 988 1833) or e-mail (jgv@sgm.ac.uk), but the corrected proof should still be mailed. A copy of the proof should be retained by the authors. Extensive changes at the proof stage are not permitted. Authors may be charged for correction of their non-typographical errors.
Offprints
Twenty-five offprints are provided free of charge. Additional copies may be ordered at prices given on the order form which accompanies the proofs. The order form should be completed and returned to the Editorial Office with the proof, irrespective of whether additional offprints are required. Later orders are subject to increased prices. Click here to download an Offprint Order form.
Charges
There are no handling or page charges.
Ethics of human and animal work
A paper describing any experimental work with humans should include a statement that the Ethics Committee of the institution in which the work was done has approved it, and that the subjects gave informed consent to the work.
Experiments with animals should be done in accordance with the legal requirements of the relevant local or national authority. Procedures should be such that animals used in experiments do not suffer unnecessarily. Papers should include details of the procedures and of anaesthetics used. The Editors will not accept papers where the ethical aspects are, in their opinion, open to doubt.
By publishing in Journal of General Virology authors agree that any viruses, plasmids and living materials, such as cell lines or bacterial strains, that are newly described within the article are available without unnecessary delay and at a reasonable cost to members of the scientific community for non-commercial purposes.
An indication of this should be given. Variability should be indicated statistically wherever possible; when error terms are given, the measure of dispersion and the number of observations should be stated. Statistical techniques used must be specified.
|
Abbreviations for units and virus names are dealt with below. The use of abbreviations is permitted in JGV but they should aid the reader and not simply be a convenience to the author; therefore, their use should be limited. As a general rule, if the abbreviation is used less than three times in the text, it should be removed. All abbreviations should be defined in full and introduced in parentheses at the first mention in both the summary and the main text. For example, 'cells were cultured in Dulbecco's modified Eagle's medium (DMEM).' To download a PDF listing permitted and compulsory abbreviations, click here. |
Quantities, units and symbols
The recommended SI units should be used. Concentrations should be indicated by the use of superscripts rather than a solidus, e.g. mg ml-1 rather than mg/ml. There should be a space between a number and a unit, e.g. 3? kb not 3?kb; 37 癈 not 37癈.
Molecular mass, Mr and K
The mass of a molecule should be specified in one of two ways:
(i) Mr ('relative molecular mass'). This is the ratio of the mass of a molecule to 1/12 of the mass of 12C; it is thus a pure number and has no units.
(ii) Molecular mass (not 'molecular weight'). This is the absolute mass of a molecule expressed in daltons (Da); the dalton is defined as 1/12 of the mass of 12C. A protein can be said to have an Mr of 20000 or a molecular mass of 20 kDa. It is incorrect to express Mr in daltons or to use 'K' to represent an Mr of 1000 or 1 kDa. A number followed by K (e.g. 15K) may be used as a designation of a compound. This designation must be defined when it first appears: e.g. 'the protein with an Mr of 15000/molecular mass of 15 kDa (15K protein)'.
Virus nomenclature
Virus names should be given in full in the title of the paper and at their first occurrence in the Summary and in the main body of the text. Where appropriate a precise strain designation should be included. Names should follow the standard nomenclature set out by the International Committee on Taxonomy of Viruses [Virus Taxonomy: Classification and Nomenclature of Viruses. Seventh Report of the International Committee on Taxonomy of Viruses (2000). Edited by M. H. V. Van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, D. J. McGeoch, J. Maniloff, M. A. Mayo, C. R. Pringle & R. B. Wickner. San Diego: Academic Press]. This volume also includes the standard abbreviations for viruses.
Formal taxonomic nomenclature
In formal taxonomic usage, the first letters of virus order, family, subfamily, genus and species names are capitalized and the terms are printed in italics. Other words in the species name are not capitalized unless they are proper nouns or parts of proper nouns. Examples of correct spelling and typographical style for the corresponding taxonomic entities are Tobacco mosaic virus, Poliovirus and Murray River encephalitis virus (River is a proper noun).
Italics and capital letters need to be used only if the species name refers to a taxonomic category. Taxonomic names are not appropriate when referring to physical entities such as virions. Here, names are written in lower-case roman type. This corresponds to informal vernacular usage and is appropriate, for instance, when picornaviruses (not italicized) or poliovirus particles are being centrifuged or are visualized in a microscope. This also applies when the names are used in adjectival form, for instance tobacco mosaic virus polymerase.
The use of italics when referring to the name of a species as a taxonomic entity will clearly signal that it has the status of an officially recognized species. When the taxonomic status of a new putative species is uncertain or its positioning within an established genus has not been clarified, it will be considered a 'tentative' species and its name will not be given in italics, although its initial letter will be capitalized.
In formal taxonomic usage, the name of the taxon precedes the term for the taxonomic unit (e.g. 'the family Paramyxoviridae', 'the genus Morbillivirus'). The following are examples of taxonomic terminology: family Picornaviridae, genus Enterovirus, Poliovirus 1; family Bunyaviridae, genus Tospovirus, Tomato spotted wilt virus.
Vernacular virus nomenclature
In informal vernacular usage, virus order, family, subfamily, genus and species names are written in lower-case roman type; they are not capitalized, printed in italics or underlined. In informal usage, the name of the taxon should not include the formal suffix, and the name should follow the term for the taxonomic unit (e.g. the picornavirus family, the enterovirus genus). The use of vernacular terms should not lead to unnecessary ambiguity or loss of precision in virus identification. In particular, care must be taken over the hierarchical level being cited: thus the vernacular name 'paramyxovirus' might refer to the family Paramyxoviridae, the genus Paramyxovirus, or one of the species in that genus. The solution is to avoid 'jumping' hierarchical levels and to add taxon identification whenever needed.
Genes and proteins
Authors should be guided by the recommendations of M. Demerec et al. (Genetics 54, 61?6, 1966) where these are relevant to virus genetics. Particular care should be taken to distinguish between genes (e.g. gag ) and the proteins that they encode (e.g. Gag, p15gag).
Such papers should be accompanied by substantial additional experimentation to characterize the gene(s) and product(s) concerned, and/or substantial comparable analysis. A sequence alone is unlikely to be acceptable.
Papers reporting new sequence data will not be published unless the sequence has an accession number from a recognized nucleotide database. Manuscripts containing sequence data should include, on the title page, the footnote 'The GenBank [or EMBL or DDBJ, etc.] accession number of the sequence reported in this paper is X00000'.
Comparison of sequence data
When making comparisons between nucleotide or amino acid sequences it is important to use the correct terminology. 'Homology' has a precise biological meaning of 'having a common evolutionary origin'. When a percentage comparison is made, the terms identity or similarity, as appropriate, must be used.
Editorial Board
| Editor |
Address |
Subject area |
|
Editor-in-Chief
G. L. Smith |
Department of Virology,
Faculty of Medicine,
Imperial College,
St Mary's Campus,
Norfolk Place,
London W2 1PG, UK
Fax +44 20 7594 3973
E-mail glsmith@imperial.ac.uk |
Review Articles
Poxviruses |
|
| C. R. M. Bangham |
Department of Immunology,
Wright-Fleming Institute,
Faculty of Medicine,
Imperial College St Mary's Campus,
London W2 1PG, UK
Fax +44 20 7402 0653
E-mail c.bangham@imperial.ac.uk |
Retroviruses (immunology, dynamics) |
|
| A. J. Davison |
MRC Virology Unit,
Institute of Virology,
University of Glasgow,
Church Street,
Glasgow G11 5JR, UK
Fax +44 141 337 2236
E-mail a.davison@vir.gla.ac.uk |
Herpesvirus genomics
Adenoviruses |
|
| D. J. Evans |
Institute of Virology,
University of Glasgow,
Church Street,
Glasgow G11 5JR, UK
Fax +44 141 337 2236
E-mail djejgv1@ucdf.gla.ac.uk |
Picornaviruses and other positive-strand RNA viruses |
|
| P. J. Farrell |
Ludwig Institute for Cancer Research,
Faculty of Medicine,
Imperial College,
St Mary's Campus,
Norfolk Place,
London W2 1PG, UK
Fax +44 20 7724 8586
E-mail p.farrell@imperial.ac.uk |
Herpesviruses (especially EBV, KSHV) |
|
|
| B. Gronenborn |
Institut des Sciences Vegetales,
CNRS,
Avenue de la Terrasse,
91198 Gif-sur-Yvette Cedex,
France
Fax +33 1 69 82 36 95
E-mail gronenborn@isv.cnrs-gif.fr |
Plant DNA viruses |
|
| T. J. Harrison |
Centre for Hepatology,
Royal Free Campus (UCL),
Rowland Hill Street,
London NW3 2PF, UK
Fax +44 20 7433 2852
E-mail T.Harrison@rfc.ucl.ac.uk |
Hepadnaviruses
Spumaviruses
Hepatitis C virus |
|
| L. A. King |
School of Biological and Molecular Sciences,
Oxford Brookes University,
Oxford OX3 0BP, UK
Fax +44 1865 483 242
E-mail laking@brookes.ac.uk |
Insect viruses |
|
| J. W. McCauley |
Institute for Animal Health,
Compton Laboratory,
Compton,
Berkshire RG20 7NN, UK
Fax +44 1635 577 263
E-mail johnmcc.jgv@bbsrc.ac.uk |
Positive-sense RNA viruses (especially pestiviruses and picornaviruses)
Negative-sense RNA viruses (especially influenza viruses of birds)
TSE agents |
|
| J. Ort韓 |
Consejo Superior de Investigaciones Cient靎icas,
Centro Nacional de Biotecnologia,
Campus Universidad Aut髇oma,
Cantoblanco, 28049 Madrid, Spain
Fax +34 91 585 4506
E-mail ortinjgv@cnb.uam.es |
Negative-sense RNA viruses
Orthomyxoviridae |
|
| P. F. Palukaitis |
Scottish Crop Research Institute,
Invergowrie,
Dundee DD2 5DA, UK
Fax +44 1382 562 426
E-mail ppaluk@scri.sari.ac.uk |
Positive-sense RNA plant viruses
Viroids
Satellites |
|
|
| J. T. Schiller |
Laboratory of Cellular Oncology,
National Cancer Institute,
National Institutes of Health,
Bldg 37,
Rm 4106,
Bethesda MD 20892-4040, USA
Fax +1 301 480 5322
E-mail schillej@dc37a.nci.nih.gov |
Papovaviridae |
|
| S. Schneider-Schaulies |
Institute for Virology and Immunobiology,
University of W黵zburg,
Versbacher Str. 7,
D-97078 W黵zburg,
Germany
Fax +49 931 201 49553
E-mail s-s-s@vim.uni-wuerzburg.de |
Negative-stranded RNA viruses (mainly non-segmented)
Virus immunology |
|
| E. J. Snijder |
Molecular Virology Laboratory,
Dept of Medical Microbiology,
Leiden University Medical Center,
LUMC E4-P, Room P4-26,
PO Box 9600,
2300 RC Leiden,
The Netherlands
Fax +31 71 526 6761
E-mail E.J.Snijder@LUMC.nl |
Nidoviruses and other positive-strand RNA viruses
(molecular biology and evolution) |
|
|
|
|
| S. Wain-Hobson |
Unit?de R閠rovirologie Mol閏ulaire,
Institut Pasteur,
28 rue du Dr Roux,
F-75724 Paris cedex 15,
France
Fax +33 1 45 68 88 74
E-mail simon@pasteur.fr |
Retroviruses (pathogenesis, evolution, vaccination) |
|
| G. W. G. Wilkinson |
Section of Infection and Immunity
University of Wales College of Medicine,
Tenovus Building,
Heath Park,
Cardiff CF14 4XX, UK
Fax +44 29 2074 5003
E-mail WilkinsonGW1@cardiff.ac.uk |
Betaherpesviruses
Adenoviruses
Immune evasion |
|
A. Alcami (Spain)
T. Barrett (UK)
R. Bartenschlager (Germany)
P. M. Beard (Switzerland)
G. E. Blair (UK)
P. Borrow (UK)
A. Bridgen (UK)
M. Bruce (UK)
R. M. L. Buller (USA)
J. Butel (USA)
J. C. de la Torre (USA)
P. E. Digard (UK)
E. Domingo (Spain)
R. Doms (USA)
J. Dubuisson (France)
R. M. Elliott (UK)
L. Enjuanes (Spain)
J. A. M. Escribano (Spain)
H. Feldmann (Canada)
T. Frischmuth (Germany)
S. Fuller (UK)
A. Gessain (France)
R. W. Goldbach (Netherlands)
|
U. A. Gompels (UK)
D. Gonzalez Dunia (France)
A. E. Gorbalenya (Netherlands)
K. Y. Green (USA)
S. D. Hayward (USA)
Y. Kawaoka (USA, Japan)
R. Kettmann (Belgium)
R. Kurth (Germany)
M. Malim (UK)
T. C. Mettenleiter (Germany)
M. Nassal (Germany)
O. Haller (Germany)
P. O'Hare (UK)
J. A. Jehle (Germany)
A. H. Patel (UK)
R. D. Possee (UK)
C. M. Preston (UK)
A. Rethwilm (Germany)
F. Rey (France)
K. E. Richards (France)
J. Rommelaere (Germany)
M. J. Roossinck (USA)
M. Rowe (UK)
|
P. Roy (UK)
R. W. H. Ruigrok (France)
Q. Sattentau (UK)
M. J. Schnell (USA)
T. F. Schulz (Germany)
S. G. Siddell (UK)
A. J. Sinclair (UK)
J. G. P. Sissons (UK)
J. Stanley (UK)
M. Stevenson (USA)
J. P. Stuart (UK)
A. Storey (UK)
J. P. Stoye (UK)
W. Sugden (USA)
M. E. Taliansky (UK)
H.-J. Thiel (Germany)
A. R. Thomsen (Denmark)
N. Tordo (France)
J. F. J. M. van den Heuvel (Netherlands)
M. D. Weitzman (USA)
F. M. Zerbini (Brazil)
D. Zuidema (Netherlands) |
|
刊名字顺( Alphabetical List of Journals):
返回页首 